Labcorp Holdings Inc. upgraded to Buy: resilient diagnostics demand, strong Q2, modest valuation and new tests offset ...

The global NICU genetic testing market is forecast to grow from USD 1.74 billion in 2026 to USD 4.80 billion by 2036, at a 10.67% CAGR. Growth is driven by rising neonatal genetic disorders, rapid ...

Labcorp has acquired MLM Medical Labs, a global central and specialty laboratory provider with operations across the United ...

MLM Medical Labs is a central and specialty lab services provider supporting clinical trials, biomarker testing, and drug development for life sciences and biopharma companies.

Great Point Partners has sold portfolio company MLM Medical Labs to Labcorp, completing an exit of a global central and specialty laboratory provider serving the clinical trials and biopharmaceutical ...

According to MarketsandMarkets™, the Healthcare Analytical Testing Services Market is projected to reach USD 12,470 million by 2031 from ...

The US Food and Drug Administration has cleared Roche and partner Eli Lilly’s blood test to help ​identify signs of Alzheimer’s disease in people age ‌55 and older with cognitive decline.

Usually not, with one large exception. Standard drug panels don't test for muscimol, the active compound in the Amanita ...

Labcorp Holdings Inc. ( LH ), a laboratory services provider, on Tuesday announced that it has acquired MLM Medical Labs, a central and specialty laboratory provider with operations across the United ...

Acquisition establishes Labcorp as the only central laboratory provider with a wholly owned laboratory network across four continents In addition, the acquisition strengthens Labcorp's scientific and ...

Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look ...

Testing for Alzheimer’s-related brain changes has traditionally depended on procedures that can be expensive, invasive, or difficult to access. Roche Holding AG and Eli Lilly and Company (NYSE:LLY) ...